Cookie Settings
Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Other cookies are those that are being identified and have not been classified into any category as yet.

No cookies to display.

Business Model

MPP improves access to affordable and appropriate essential medicines in LMICs. It does this by addressing a key challenge in equitable access to treatment – the need for multiple sources of affordable, quality-assured medicines for use in developing countries.

Disease Experts View MPP’s Expert Advisory Group &Scientific Advisory Panel Civil Society & Patient Groups Help identify treatment needs Partners View our partners View our prioritisation work The World Health Organization works with MPP to prioritise medicines and forecast future uptake Patent holders agree to license their medicines to MPP View MPP’s licences MPP sublicenses rights to manufacture these treatments to generic pharmaceutical companies View the progress of MPP manufacturing partners in treatment development and supply View MPP’s key features Licensing terms encourage the sale of low-cost versions of essential medicines and treatments Licensing mechanism accelerate the development of better-adapted medicines: fixed-dose combinations and formulations for children View MPP’s paediatric work View MPP’s impact New treatments become available faster to the peoplewho need them most Generic competition brings prices down and more people gain access to treatments View MPP’s contribution to Universal Health Coverage licences signed 0 generic manufacturing partners working with MPP 0 products distributed in more than a 100 developing countries 0
MPP Logo

Subscribe to our Newsletter

Founded & funded by

Unitaid Logo

Other funders